Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH)

NCT ID: NCT04161716

Last Updated: 2021-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-07

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

NIRS technology is therefore a technique that exploits the different absorption properties of oxygenated and deoxygenated hemoglobin to evaluate the degree of tissue oxygenation. This hemodynamic response is measured in a completely non-invasive and silent manner, by the simple emission of light passing through different layers of biological tissue.

In the literature, some studies concerning the use of the NIRS method for the study of urodynamics exist. They seem to show a correlation between the data of the urodynamic assessment and the data obtained with the NIRS method. Certain trends seem to be repeated with, for example, an increase in oxyhemoglobin at the beginning of the filling phase and the beginning of the urination phase.

The aim of the study is to analyze the NIRS signal and find correlation with urodynamic data.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective is to detect a urodynamic variation of the detrusor muscle during a contraction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Disorders Urinary Incontinence Urinary Bladder Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Urodynamic bladder detrusor urinary disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

NIRS module recording
Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NIRS module

Each patient has a NIRS module during a diagnosis urodynamic assessment provided for by the usual practice.

Group Type EXPERIMENTAL

NIRS recording

Intervention Type DEVICE

Patient has a NIRS module during their urodynamic exam.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NIRS recording

Patient has a NIRS module during their urodynamic exam.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Person whose urodynamic evaluation for diagnosis purposes is necessary
* Male or female ≥ 18 years
* Person affiliated with a social security scheme
* ECBU / BU negative

Exclusion Criteria

* Minors
* Pregnant or parturient or lactating women
* Refusal of consent
* Contraindications usually provided for the realization of a Urodynamic exam
* Sensory disturbances making the participant insensitive to pain
* Motor or mental disorders that prevent the participant from expressing pain
* Behavioral problems that make the participant excessively agitated or aggressive
* Irritation and / or erythema, or open sore in the area covered by the NIRS
* Half-sitting position impossible
* Tattoo or stretch mark in the lower abdomen or pubic area
* External cutaneous or internal scar in the area covered by the NIRS
* Allergy to a component of the textile part of the device: polyamide, cotton, polyester, elastane, silver, other synthetic materials
* Simultaneous participation in another search
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

BioSerenity

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rangueil Hospital

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A02770-57

Identifier Type: -

Identifier Source: org_study_id